You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 56 No. 4, April 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Observation
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Coma/ Vegetative State
 •Alert me on articles by topic

Successful Use of Alternate Waste Nitrogen Agents and Hemodialysis in a Patient With Hyperammonemic Coma After Heart-Lung Transplantation

Gerard T. Berry, MD; Nancy D. Bridges, MD; Katherine L. Nathanson, MD; Paige Kaplan, MD; Robert R. Clancy, MD; Gary R. Lichtenstein, MD; Thomas L. Spray, MD

Arch Neurol. 1999;56:481-484.

Background  Lethal hyperammonemic coma has been reported in 2 adults after lung transplantation. It was associated with a massive elevation of brain glutamine levels, while plasma glutamine levels were normal or only slightly elevated. In liver tissue, glutamine synthetase activity was markedly reduced, and the histologic findings resembled those of Reye syndrome. The adequacy of therapy commonly used for inherited disorders of the urea cycle has not been adequately evaluated in patients with this form of secondary hyperammonemia.

Objective  To determine whether hemodialysis, in conjunction with intravenous sodium phenylacetate, sodium benzoate, and arginine hydrochloride therapy, would be efficacious in a patient with hyperammonemic coma after solid-organ transplantation.

Design  Case report.

Setting  A children's hospital.

Patient  A 41-year-old woman with congenital heart disease developed a hyperammonemic coma with brain edema 19 days after undergoing a combined heart and lung transplantation.

Methods  Ammonium was measured in plasma. Amino acids were quantitated in plasma and cerebrospinal fluid by column chromatography. The effectiveness of therapy was assessed by measuring plasma ammonium levels and intracranial pressure and performing sequential neurological examinations.

Results  The patient had the anomalous combination of increased cerebrospinal fluid and decreased plasma glutamine levels. To our knowledge, she is the first patient with this complication after solid-organ transplantation to survive after combined therapy with sodium phenylacetate, sodium benzoate, arginine hydrochloride, and hemodialysis. Complications of the acute coma included focal motor seizures, which were controlled with carbamazepine, and difficulty with short-term memory.

Conclusions  The aggressive use of hemodialysis in conjunction with intravenous sodium phenylacetate, sodium benzoate, and arginine hydrochloride therapy may allow survival in patients after solid-organ transplantation. An acute acquired derangement in extra–central nervous system glutamine metabolism may play a role in the production of hyperammonemia in this illness that resembles Reye syndrome, and, as in other hyperammonemic disorders, the duration and degree of elevation of brain glutamine levels may be the important determining factors in responsiveness to therapy.


From the Departments of Pediatrics (Drs Berry, Bridges, Nathanson, and Kaplan), Neurology (Dr Clancy), Medicine (Dr Lichtenstein), and Surgery (Dr Spray), University of Pennsylvania School of Medicine; the Department of Pediatrics, Divisions of Biochemical Development and Molecular Diseases (Drs Berry, Nathanson, and Kaplan) and Cardiology (Dr Bridges), and the Departments of Neurology (Dr Clancy) and Cardiothoracic Surgery (Dr Spray), The Children's Hospital of Philadelphia; and the Department of Medicine, Division of Gastroenterology, Hospital of the University of Pennsylvania (Dr Lichtenstein), Philadelphia.


RELATED ARTICLE

Archives of Neurology Reader's Choice: Continuing Medical Education
Arch Neurol. 1999;56(4):493-495.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Critical Care Aspects of Lung Transplantation
Lau et al.
J Intensive Care Med 2004;19:83-104.
ABSTRACT  

Medical complications of lung transplantation
Kotloff and Ahya
Eur Respir J 2004;23:334-342.
ABSTRACT | FULL TEXT  

Aortic homograft interposition for management of complete tracheal anastomotic disruption after heart-lung transplantation
Hoffman et al.
J. Thorac. Cardiovasc. Surg. 2001;121:587-588.
FULL TEXT  

Hyperammonia Possibly due to Corticosteroids
Hawley et al.
Arch Neurol 2000;57:1085-1085.
FULL TEXT  

Fatal Hyperammonemia after Orthotopic Lung Transplantation
Lichtenstein et al.
ANN INTERN MED 2000;132:283-287.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.